Mechanism of immunopotentiation by aluminum-containing adjuvants elucidated by the relationship between antigen retention at the inoculation site and the immune response

Vaccine

Volumn 28, Issue 20, 2010, Pages 3588-3594

  Noe, Stephanie M ^a   Green, Mark A ^b   HogenEsch, Harm ^c   Hem, Stanley L ^a  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

^c PURDUE UNIVERSITY   (United States)

Author keywords

Aluminum containing adjuvants; Immunopotentiation; Retention at inoculation site

Indexed keywords

ALPHA CASEIN; ALUMINUM HYDROXIDE; ALUMINUM PHOSPHATE; ANTIGEN; IMMUNOLOGICAL ADJUVANT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG ABSORPTION; DRUG RETENTION; GAMMA SCINTIGRAPHY; IMMUNE RESPONSE; IMMUNOPOTENTIATION; LYMPH NODE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADJUVANTS, IMMUNOLOGIC; ADSORPTION; ALUMINUM COMPOUNDS; ALUMINUM HYDROXIDE; ANIMALS; ANTIBODY FORMATION; ANTIGENS; CASEINS; HUMANS; MALE; PHOSPHATES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77950596439     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.02.085     Document Type: Article

References (37)

1. Glenny A., Pope C., Waddington H., and Wallace V. The antigenic value of toxoid precipitated by potassium alum. J Pathol Bacteriol 29 (1926) 38-45
2. Romero Mendez I.Z., Shi Y., HogenEsch H., and Hem S.L. Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants. Vaccine 25 (2007) 825-833
3. 14C-labeled tetanus toxoid. Vaccine 14 (1996) 1412-1416
4. MacLean D.S., Robertson J.D., Jay M., and Stalker D.J. Noninvasive measurement of protein release from subcutaneous depo-formations in vivo using X-ray fluorescence. J Control Release 34 (1995) 147-173
5. 123/131I-Il-8): biological behavior in a mouse infection model. Appl Radiat Isot 62 (2005) 39-47
6. 14C formol. Ann Inst Pasteur (Paris) 116 (1969) 501-521
7. Josefsson M., Grunditz T., Ohlsson T., and Ekblad E. Sodium/iodide symporter: distribution in different mammals and role in entero-thyroid circulation of iodide. Acta Physiol Scand 175 (2002) 129-137
8. Perez-Romero P., and Imperiale M.J. Assaying protein-DNA interactions in vivo and in vitro using chromatin immunoprecipitation and electrophoretic mobility shift assays. Methods Mol Med 131 (2007) 123-139
9. Rosenberg I.N., and Goswami A. Iodotyrosine deiodinase from bovine thyroid. Methods Enzymol 107 (1984) 488-500
10. Song S.H., Jung K.H., Palk J.Y., Koh B.H., Bae Y.S., Choe Y.S., et al. Distribution and pharmacokinetic analysis of angiostatin radioiodine labeled with high stability. Nucl Med Biol 32 (2005) 845-850
11. Sun X., Chu T., Liu X., and Wang X. t-Butyloxycarbonyl: an ordinary but promising group for protecting peptides from deiodination. Appl Radiat Isot 64 (2006) 645-650
12. Landel A.M. Stability studies on fluorescein isothiocyanate-bovine serum albumin conjugate. Anal Biochem 73 (1976) 280-289
13. Schroder U., Arfors K.E., and Tangen O. Stability of fluorescein labeled dextrans in vivo and in vitro. Macrovasc Res 11 (1976) 57-66
14. 99Y-labeled DOTA analogues conjugated to B72.3. Nucl Med Biol 34 (2007) 493-502
15. Mercier J.C., Grosclaude F., and Ribadeau-Dumas B. Primary structure of bovine sl casein. Eur J Biochem 23 (1971) 41-51
16. Peters Jr. T. The biosynthesis of rat serum albumin. III. Amino acid composition of rat albumin. J Biol Chem 237 (1962) 2182-2183
17. Samuels M.L., and Witmer J.A. Statistics for the life sciences (2003), Pearson Educational, Upper Saddle River p. 288-300
18. Chang M.-F., Shi Y., Nail S.L., HogenEsch H., Adams S.B., White J.L., et al. Degree of antigen adsorption in the vaccine or interstitial fluid and its effect on the antibody response in rabbits. Vaccine 19 (2001) 2884-2889
19. Hansen B., Sokolovska A., HogenEsch H., and Hem S.L. Relationship between the strength of antigen adsorption to an aluminum-containing adjuvant and the immune response. Vaccine 25 (2007) 6618-6624
20. Jiang D., Morefield G.L., HogenEsch H., and Hem S.L. Relationship of adsorption mechanism of antigens by aluminum-containing adjuvants to in vitro elution in interstitial fluid. Vaccine 24 (2006) 1665-1669
21. Iyer S., HogenEsch H., and Hem S.L. Effect of the degree of phosphate substitution in aluminum hydroxide adjuvant on the adsorption of phosphorylated proteins. Pharm Dev Technol 8 (2003) 81-86
22. Guyton S.C., and Hall J.E. Textbook of medical physiology (2000), Saunders, Philadelphia p. 162-74
23. Itano A.A., McSorley S.J., Reinhardt R.L., Ehst B.D., Ingulli E., Rudensky A.Y., et al. Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity 19 (2003) 47-57
24. Morefield G.L., Sokolovska A., Jiang D., HogenEsch H., Robinson J.P., and Hem S.L. Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro. Vaccine 23 (2005) 1588-1593
25. 26Al. Vaccine 15 (1997) 1314-1318
26. Rinella Jr. J.V., White J.L., and Hem S.L. Effect of pH on the elution of model antigens from aluminum-containing adjuvants. J Colloid Interface Sci 205 (1998) 161-165
27. Guyton S.C., and Hall J.E. Textbook of medical physiology (2000), Saunders, Philadelphia p. 392-400
28. Goto N., Kato H., Maeyama J., Shibano M., Saito T., Yamaguchi J., et al. Local tissue irritation effects and adjuvant activities of calcium phosphate and aluminum hydroxide with different physical properties. Vaccine 15 (1997) 1364-1371
29. Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 6 (2006) 173-182
30. Hansen B., Belfast M., Soung G., Song L., Egan P.M., Capen R., et al. Effect of the strength of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant on the immune response. Vaccine 27 (2009) 888-892
31. Egan P.M., Belfast M.T., Gimenez J.A., Sitrin R.D., and Mancinelli R.J. Relationship between tightness of binding and immunogenicity in an aluminum-containing adjuvant adsorbed hepatitis B vaccine. Vaccine 27 (2009) 3175-3180
32. Naim J.O., van Oss C.J., Wu W., Giese R.R., and Nickerson P.A. Mechanisms of adjuvancy. I. Metal oxides as adjuvants. Vaccine 15 (1997) 1364-1371
33. + T cell differentiation by aluminum-containing adjuvants. Vaccine 25 (2007) 4575-4585
34. Kool M., Soullie T., van Nimwegen M., Willart M.A.M., Muskens F., Jung S., et al. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J Exp Med 205 (2008) 869-882
35. Eisenbarth S.C., Colegio O.R., O'Connor Jr. W., Sutterwala F.S., and Falvell R.A. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminum adjuvants. Nature 453 (2008) 1122-1126
36. Lambrecht B.N., Kool M., Willart M.A.M., and Hammad H. Mechanism of action of clinically approved adjuvants. Curr Opin Immunol 21 (2009) 23-29
37. Marrack P., McKee A.S., and Munks M.W. Towards an understanding of the adjuvant action of aluminum. Nat Rev Immunol 9 (2009) 287-293